Literature DB >> 15789269

Postreassortment changes in a model system: HA-NA adjustment in an H3N2 avian-human reassortant influenza virus.

N A Ilyushina1, I A Rudneva, A A Shilov, H-D Klenk, N V Kaverin.   

Abstract

In our previous studies we described the postreassortment changes in the hemagglutinin (HA) of H2N1, H3N1, H4N1 and H13N1 influenza A virus reassortants with HAs derived from avian viruses and low-functional neuraminidase (NA) of a human parent virus A/USSR/90/77 (H1N1). The changes involved amino acid substitutions that increased the negative local charge in the vicinity of the receptor-binding pocket and decreased the affinity of HA to sialic acid receptors. In the present report we describe the studies performed with H3N2 reassortant viruses having HA of A/Duck/Ukraine/1/63 (H3N8) virus and NA of A/Aichi/2/68 (H3N2) virus. Amino acid changes in the HA gene registered in virus variants selected in the course of serial passages resulted in a decrease in the affinity to sialic acid-containing substrates and cell receptors. However, the decrease was less expressed than in the reassortants containing the low-functional NA of N1 subtype described in our earlier studies, and the amino acid changes were not necessarily associated with an increase of negative charge. In one passage variant an amino acid substitution in NA was detected. The relevance of these results for the evolution of the H3N2 virus of the 1968 pandemic is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789269     DOI: 10.1007/s00705-005-0490-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

Review 1.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

2.  The age distribution of mortality due to influenza: pandemic and peri-pandemic.

Authors:  Tom Reichert; Gerardo Chowell; Jonathan A McCullers
Journal:  BMC Med       Date:  2012-12-12       Impact factor: 8.775

3.  Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors.

Authors:  Larisa Mochalova; Rick Bright; Xiyan Xu; Elena Korchagina; Alexander Chinarev; Nicolai Bovin; Alexander Klimov
Journal:  Glycoconj J       Date:  2010-03-02       Impact factor: 2.916

4.  Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses.

Authors:  Yulia Shtyrya; Larisa Mochalova; Galina Voznova; Irina Rudneva; Aleksandr Shilov; Nikolai Kaverin; Nicolai Bovin
Journal:  Glycoconj J       Date:  2008-07-26       Impact factor: 2.916

Review 5.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

Review 6.  Reassortment in segmented RNA viruses: mechanisms and outcomes.

Authors:  Sarah M McDonald; Martha I Nelson; Paul E Turner; John T Patton
Journal:  Nat Rev Microbiol       Date:  2016-05-23       Impact factor: 60.633

7.  Compensatory evolution of net-charge in influenza A virus hemagglutinin.

Authors:  Yuki Kobayashi; Yoshiyuki Suzuki
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

8.  A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead.

Authors:  Catherine A A Beauchemin; Andreas Handel
Journal:  BMC Public Health       Date:  2011-02-25       Impact factor: 3.295

9.  Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity.

Authors:  Mathilde Richard; Alexandra Erny; Bertrand Caré; Aurélien Traversier; Mendy Barthélémy; Alan Hay; Yi Pu Lin; Olivier Ferraris; Bruno Lina
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.